Target Volume Coverage and Organ at Risk Doses for Left-sided Whole-breast Irradiation With or Without Internal Mammary Chain Irradiation: A Comparison Between Three Techniques Representing the Past and the Present

Model based patient pre-selection for intensity-modulated proton therapy (IMPT) using automated treatment planning and machine learning

(2021) Jasper Kouwenberg et al.   RADIOTHERAPY AND ONCOLOGY

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward

(2021) David Krug et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925

(2021) Philip M Poortmans et al.   JNCI-Journal of the National Cancer Institute

Effect of breathing motion on robustness of proton therapy plans for left-sided breast cancer patients with indication for locoregional irradiation

(2020) L. Klaassen et al.   ACTA ONCOLOGICA

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial

(2020) Philip M Poortmans et al.   LANCET ONCOLOGY

Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study)

(2019) Sophie Jacob et al.   Radiation Oncology

Quantification of Acute Skin Toxicities in Patients With Breast Cancer Undergoing Adjuvant Proton versus Photon Radiation Therapy: A Single Institutional Experience

(2019) Cristina M. DeCesaris et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Practical robustness evaluation in radiotherapy – A photon and proton-proof alternative to PTV-based plan evaluation

(2019) Erik W. Korevaar et al.   RADIOTHERAPY AND ONCOLOGY

A Dosimetric Comparison of Breast Radiotherapy Techniques to Treat Locoregional Lymph Nodes Including the Internal Mammary Chain

(2018) A. Ranger et al.   CLINICAL ONCOLOGY

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

(2017) Carolyn Taylor et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures

(2017) Veerle A.B. van den Bogaard et al.   JOURNAL OF CLINICAL ONCOLOGY

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1

(2016) Birgitte V. Offersen et al.   RADIOTHERAPY AND ONCOLOGY

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer

(2015) Birgitte V. Offersen et al.   RADIOTHERAPY AND ONCOLOGY

Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients

(2014) Mirjam E. Mast et al.   BREAST CANCER RESEARCH AND TREATMENT

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

(2013) Sarah C. Darby et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved efficiency of multi-criteria IMPT treatment planning using iterative resampling of randomly placed pencil beams

(2013) S van de Water et al.   PHYSICS IN MEDICINE AND BIOLOGY

Left-sided breast cancer radiotherapy with and without breath-hold: Does IMRT reduce the cardiac dose even further?

(2013) Mirjam E. Mast et al.   RADIOTHERAPY AND ONCOLOGY

Correlation of 2D parameters to lung and heart dose-volume in radiation treatment of breast cancer

(2012) Indra J. Das et al.   ACTA ONCOLOGICA

Postoperative Proton Radiotherapy for Localized and Locoregional Breast Cancer: Potential for Clinically Relevant Improvements?

(2009) Carmen Ares et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS